You are here » Home » Companies » Company Overview » Kokuyo Camlin Ltd

Kokuyo Camlin Ltd.

BSE: 523207 Sector: Services
NSE: KOKUYOCMLN ISIN Code: INE760A01029
BSE 00:00 | 25 Apr 94.90 0.80
(0.85%)
OPEN

95.35

HIGH

96.00

LOW

93.75

NSE 00:00 | 25 Apr 94.30 -0.60
(-0.63%)
OPEN

94.95

HIGH

95.85

LOW

93.15

OPEN 95.35
PREVIOUS CLOSE 94.10
VOLUME 2440
52-Week high 154.00
52-Week low 83.20
P/E 57.87
Mkt Cap.(Rs cr) 952
Buy Price 93.75
Buy Qty 15.00
Sell Price 95.95
Sell Qty 20.00
OPEN 95.35
CLOSE 94.10
VOLUME 2440
52-Week high 154.00
52-Week low 83.20
P/E 57.87
Mkt Cap.(Rs cr) 952
Buy Price 93.75
Buy Qty 15.00
Sell Price 95.95
Sell Qty 20.00

Kokuyo Camlin Ltd. (KOKUYOCMLN) - Company History

Incorporated to take over the business of Dandekar & Company, Camlin got its present name in 1988. Starting with stationery products, it has diversified into art materials and pharmaceuticals. Its products are marketed under the popular Camel and Camlin brands. Its stationery division has a wide range of products like fountain pen inks, rubber stamp inks, duplicating inks, adhesives, writing instruments and gift sets, fountain-pen nibs and ball-point pens, erasers, stamp pads, scales, carbon paper, etc. The art material division supplies water colours, oil colours, poster colours, drawing inks, crayons, oil pastels, fabric colours, painting brushes, canvas, wooden and mechanical pencils, lead, markers; mathematical, engineering and biological instruments, etc. Bulk drugs like diloxanide fuorate, mebendazole, diazepam, etc, as well as a wide range of formulations (used in treating asthma, skin diseases, rheumatism, etc) are manufactured by the pharmaceutical division. Camlin started commercial production of high polymer lead in Mar.'90, in technical collaboration with Pilot Corporation, Japan, and has become one of the few companies in the world manufacturing the product. The company's products are exported to east and west Asia, Europe, Africa, Australia, etc. Camlin has entered into a marketing alliance with Colart Fine Art and Graphics, UK, to market its Winsor & Newton premium range of colour products. Besides expanding its present manufacturing capacities, the company has also set up a plant to manufacture industrial grade synthetic adhesives, which commenced commercial production in Mar.'96. The plant for manufacturing bulk drugs/chemicals, commenced commercial production in 1995-96. Camlin International became a wholly-owned subsidiary of the company. During 1998-99, the company has raised a sum of Rs.750 lacs from IDBI through Private Placement of 16.5% Non Convertible Secured Redeemable Debentures for financing capital expenditure & long term working capital.The Erstwhile Stationery & Art Material Divisions have been merged into Consumer Products Division w.e.f. 1st April, 1999. The company undertook major expansion in production of anti-oxidant range of products.